578 related articles for article (PubMed ID: 30071857)
1. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
[TBL] [Abstract][Full Text] [Related]
2. Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007.
Dunavoelgyi R; Dieckmann K; Gleiss A; Sacu S; Kircher K; Georgopoulos M; Georg D; Zehetmayer M; Poetter R
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):199-205. PubMed ID: 20675066
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
Verma V; Mehta MP
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
[TBL] [Abstract][Full Text] [Related]
4. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
5. Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection.
Suesskind D; Scheiderbauer J; Buchgeister M; Partsch M; Budach W; Bartz-Schmidt KU; Ritz R; Grisanti S; Paulsen F
JAMA Ophthalmol; 2013 May; 131(5):630-7. PubMed ID: 23494018
[TBL] [Abstract][Full Text] [Related]
6. Early ultrasonographic tumor regression after linear accelerator stereotactic fractionated photon radiotherapy of choroidal melanoma as a predictor for metastatic spread.
Mitsch C; Zehetmayer M; Gleiss A; Georg D; Dieckmann K; Pötter R; Sayegh R; Schmidt-Erfurth U; Dunavoelgyi R
Radiother Oncol; 2018 Jun; 127(3):385-391. PubMed ID: 29747872
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma.
Yazici G; Kiratli H; Ozyigit G; Sari SY; Cengiz M; Tarlan B; Mocan BO; Zorlu F
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):152-158. PubMed ID: 28586956
[TBL] [Abstract][Full Text] [Related]
8. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma.
Kosydar S; Robertson JC; Woodfin M; Mayr NA; Sahgal A; Timmerman RD; Lo SS
Am J Clin Oncol; 2021 Jan; 44(1):32-42. PubMed ID: 33208706
[TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results.
Muller K; Naus N; Nowak PJ; Schmitz PI; de Pan C; van Santen CA; Marijnissen JP; Paridaens DA; Levendag PC; Luyten GP
Radiother Oncol; 2012 Feb; 102(2):219-24. PubMed ID: 21864922
[TBL] [Abstract][Full Text] [Related]
11. Fractionated stereotactic radiotherapy with linear accelerator for uveal melanoma--preliminary Vienna results.
Zehetmayer M; Dieckmann K; Kren G; Kitz K; Ruhswurm I; Georgopoulos M; Pötter R
Strahlenther Onkol; 1999 Jun; 175 Suppl 2():74-5. PubMed ID: 10394403
[TBL] [Abstract][Full Text] [Related]
12. Eye retention after proton beam radiotherapy for uveal melanoma.
Egger E; Zografos L; Schalenbourg A; Beati D; Böhringer T; Chamot L; Goitein G
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):867-80. PubMed ID: 12605964
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic photon beam irradiation of uveal melanoma.
Zehetmayer M
Dev Ophthalmol; 2012; 49():58-65. PubMed ID: 22042013
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up after uveal melanoma charged particle therapy.
Char DH; Kroll SM; Castro J
Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
[TBL] [Abstract][Full Text] [Related]
16. A noninvasive eye fixation and computer-aided eye monitoring system for linear accelerator-based stereotactic radiotherapy of uveal melanoma.
Bogner J; Petersch B; Georg D; Dieckmann K; Zehetmayer M; Pötter R
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1128-36. PubMed ID: 12829151
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
18. 15 years experience with helium ion radiotherapy for uveal melanoma.
Castro JR; Char DH; Petti PL; Daftari IK; Quivey JM; Singh RP; Blakely EA; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):989-96. PubMed ID: 9392536
[TBL] [Abstract][Full Text] [Related]
19. One-day session LINAC-based stereotactic radiosurgery of posterior uveal melanoma.
Furdova A; Strmen P; Waczulikova I; Chorvath M; Sramka M; Slezak P
Eur J Ophthalmol; 2012; 22(2):226-35. PubMed ID: 21534252
[TBL] [Abstract][Full Text] [Related]
20. Ten-year follow-up of helium ion therapy for uveal melanoma.
Char DH; Kroll SM; Castro J
Am J Ophthalmol; 1998 Jan; 125(1):81-9. PubMed ID: 9437317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
